Maitri Enterprises Ltd
Incorporated in 1991, Maitri Enterprises Ltd is engaged in the business of Pharmaceutical products
- Market Cap ₹ 15.7 Cr.
- Current Price ₹ 35.8
- High / Low ₹ 51.3 / 18.7
- Stock P/E 16.4
- Book Value ₹ 10.7
- Dividend Yield 0.00 %
- ROCE 16.1 %
- ROE 20.8 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
- Debtor days have improved from 148 to 68.9 days.
- Company's working capital requirements have reduced from 172 days to 89.3 days
Cons
- Stock is trading at 3.35 times its book value
- Company has a low return on equity of 3.56% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
4.55 | 19.92 | 13.26 | 18.93 | 28.66 | |
4.47 | 19.23 | 12.76 | 18.68 | 26.49 | |
Operating Profit | 0.08 | 0.69 | 0.50 | 0.25 | 2.17 |
OPM % | 1.76% | 3.46% | 3.77% | 1.32% | 7.57% |
0.09 | 0.06 | 0.11 | 0.13 | -1.00 | |
Interest | 0.02 | 0.32 | 0.37 | 0.73 | 0.77 |
Depreciation | 0.05 | 0.09 | 0.07 | 0.06 | 0.07 |
Profit before tax | 0.10 | 0.34 | 0.17 | -0.41 | 0.33 |
Tax % | 40.00% | 32.35% | 94.12% | 9.76% | 48.48% |
0.07 | 0.23 | 0.00 | -0.45 | 0.17 | |
EPS in Rs | 0.37 | 0.52 | 0.00 | -1.02 | 0.39 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 13% |
TTM: | 51% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 61% |
TTM: | 313% |
Stock Price CAGR | |
---|---|
10 Years: | 26% |
5 Years: | 36% |
3 Years: | 5% |
1 Year: | 28% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 4% |
Last Year: | 21% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Equity Capital | 4.40 | 4.40 | 4.40 | 4.40 | |
Reserves | 0.57 | 0.57 | 0.12 | 0.30 | |
5.72 | 6.34 | 10.54 | 6.89 | ||
6.85 | 7.09 | 6.61 | 4.77 | ||
Total Liabilities | 17.54 | 18.40 | 21.67 | 16.36 | |
0.28 | 0.24 | 0.24 | 0.24 | ||
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | |
Investments | 0.27 | 0.27 | 3.92 | 3.74 | |
16.99 | 17.89 | 17.51 | 12.38 | ||
Total Assets | 17.54 | 18.40 | 21.67 | 16.36 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
-0.39 | 0.02 | 0.06 | 3.04 | ||
-3.27 | -0.24 | -3.45 | 1.23 | ||
3.69 | 0.24 | 3.49 | -4.40 | ||
Net Cash Flow | 0.03 | 0.02 | 0.10 | -0.12 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Debtor Days | 163.81 | 205.62 | 168.71 | 68.90 | |
Inventory Days | 210.48 | 261.85 | 150.06 | 102.82 | |
Days Payable | 186.79 | 206.97 | 122.82 | 78.06 | |
Cash Conversion Cycle | 187.50 | 260.50 | 195.96 | 93.66 | |
Working Capital Days | 157.76 | 248.29 | 177.20 | 89.28 | |
ROCE % | 4.91% | 2.43% | 16.06% |
Documents
Announcements
- Closure of Trading Window 28 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jun - Audited Financial Results are published in two newspaper namely; 1. Free Press in English Edition 2. Lokmitra in Gujarati Language.
- Audited (Standalone And Consolidated) Financial Results For The Quarter And Year Ended On March 31, 2025 30 May
- Audited (Standalone And Consolidated) Financial Results For The Quarter And Year Ended On March 31, 2025 30 May
-
Board Meeting Outcome for Outcome Of 2Nd (02/2025-26) Board Meeting Of The Board
30 May - Approved audited standalone and consolidated financial results for FY ended March 31, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
a) Trading of Pharmaceutical & Medical Goods
b) Manufacturing of metal furniture
c) Trading of building materials